Sun Pharma Receives Shareholder Approval for Reclassification to Public Category
Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 27 Sept 2026, 3:47 am
Sun Pharma Receives Shareholder Approval for Reclassification to Public Category Sun Pharmaceutical Industries Limited announced that its shareholders approved the reclassification of specified entities from the 'Promoter Group' category to the 'Public' category on 26th Sep'26, pursuant to Regulation 31A of SEBI LODR Regulations. This follows earlier corporate intimations issued between May'26 and Aug'26. The resulting adjustments to the ownership structure will be reflected in the company's subsequent quarterly shareholding pattern filings submitted to stock exchanges.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
